Impact of combined hormonal contraceptives on vessels functionality

Alessandro Rabiolo, Federico Corvi, Davide Monteduro, Lucia Benatti, Maria Vittoria Cicinelli, Giovanni Fogliato, Giuseppe Querques, Francesco Bandello

Research output: Contribution to journalArticle

1 Citation (Scopus)

Abstract

Purpose: To evaluate the dynamic and static retinal vascular functionality in young females using combined hormonal contraceptive (CHC). Methods: Thirty-eight consecutive young female subjects were enrolled in this study between January 2015 and December 2015. Subjects were divided in two groups: CHC group, defined as CHC use for ≥6 months, and control group, defined as no current and prior CHC use. Participants underwent a dynamic and static retinal vessel analysis using the Dynamic Vessel Analyzer (DVA, Imedos, Jena, Germany). Results: Seventeen subjects continuously took CHC for 54.6 ± 29.3 months, while 21 subjects belonged to control group. No difference was found between the CHC and control groups for age (p = 0.1), smoking status (p = 0.6), and systolic (p = 0.3) and diastolic (p = 0.1) blood pressure. With regard to dynamic analysis, women taking CHC exhibited a marked significant vasoconstriction following flicker stimulation in comparison with control group (−2.43 ± 2.5 vs 0.63 ± 2.1, respectively; p = 0.0002). No significant difference was observed between groups for mean arterial (p = 0.2) and venous dilatations (p = 0.3), arteriovenous ratio (p = 0.09), central retinal artery equivalent (p = 0.4), and central retinal venous equivalent (p = 0.5). Conclusions: CHC may affect vessel reactivity to flicker light by increasing arteries constriction. This may reflect systemic changes in vascular functionality in subjects using CHC. Moreover, CHC should be considered as a confounding bias in studies involving DVA.

Original languageEnglish
Pages (from-to)1-6
Number of pages6
JournalArchives of Gynecology and Obstetrics
DOIs
Publication statusAccepted/In press - Aug 8 2016

Fingerprint

Contraceptive Agents
Retinal Vessels
Control Groups
Retinal Artery
Vasoconstriction
Constriction
Germany
Blood Vessels
Dilatation
Arteries
Smoking
Blood Pressure
Light

Keywords

  • Combined hormonal contraceptive
  • Dynamic vessel analyzer
  • Flicker light
  • Oral contraceptive pill
  • Retinal vessel analysis
  • Static vessel analysis

ASJC Scopus subject areas

  • Medicine(all)
  • Obstetrics and Gynaecology

Cite this

Rabiolo, A., Corvi, F., Monteduro, D., Benatti, L., Cicinelli, M. V., Fogliato, G., ... Bandello, F. (Accepted/In press). Impact of combined hormonal contraceptives on vessels functionality. Archives of Gynecology and Obstetrics, 1-6. https://doi.org/10.1007/s00404-016-4170-2

Impact of combined hormonal contraceptives on vessels functionality. / Rabiolo, Alessandro; Corvi, Federico; Monteduro, Davide; Benatti, Lucia; Cicinelli, Maria Vittoria; Fogliato, Giovanni; Querques, Giuseppe; Bandello, Francesco.

In: Archives of Gynecology and Obstetrics, 08.08.2016, p. 1-6.

Research output: Contribution to journalArticle

Rabiolo, A, Corvi, F, Monteduro, D, Benatti, L, Cicinelli, MV, Fogliato, G, Querques, G & Bandello, F 2016, 'Impact of combined hormonal contraceptives on vessels functionality', Archives of Gynecology and Obstetrics, pp. 1-6. https://doi.org/10.1007/s00404-016-4170-2
Rabiolo, Alessandro ; Corvi, Federico ; Monteduro, Davide ; Benatti, Lucia ; Cicinelli, Maria Vittoria ; Fogliato, Giovanni ; Querques, Giuseppe ; Bandello, Francesco. / Impact of combined hormonal contraceptives on vessels functionality. In: Archives of Gynecology and Obstetrics. 2016 ; pp. 1-6.
@article{4994e7cb2f4a4c31b5da2e794c731f8f,
title = "Impact of combined hormonal contraceptives on vessels functionality",
abstract = "Purpose: To evaluate the dynamic and static retinal vascular functionality in young females using combined hormonal contraceptive (CHC). Methods: Thirty-eight consecutive young female subjects were enrolled in this study between January 2015 and December 2015. Subjects were divided in two groups: CHC group, defined as CHC use for ≥6 months, and control group, defined as no current and prior CHC use. Participants underwent a dynamic and static retinal vessel analysis using the Dynamic Vessel Analyzer (DVA, Imedos, Jena, Germany). Results: Seventeen subjects continuously took CHC for 54.6 ± 29.3 months, while 21 subjects belonged to control group. No difference was found between the CHC and control groups for age (p = 0.1), smoking status (p = 0.6), and systolic (p = 0.3) and diastolic (p = 0.1) blood pressure. With regard to dynamic analysis, women taking CHC exhibited a marked significant vasoconstriction following flicker stimulation in comparison with control group (−2.43 ± 2.5 vs 0.63 ± 2.1, respectively; p = 0.0002). No significant difference was observed between groups for mean arterial (p = 0.2) and venous dilatations (p = 0.3), arteriovenous ratio (p = 0.09), central retinal artery equivalent (p = 0.4), and central retinal venous equivalent (p = 0.5). Conclusions: CHC may affect vessel reactivity to flicker light by increasing arteries constriction. This may reflect systemic changes in vascular functionality in subjects using CHC. Moreover, CHC should be considered as a confounding bias in studies involving DVA.",
keywords = "Combined hormonal contraceptive, Dynamic vessel analyzer, Flicker light, Oral contraceptive pill, Retinal vessel analysis, Static vessel analysis",
author = "Alessandro Rabiolo and Federico Corvi and Davide Monteduro and Lucia Benatti and Cicinelli, {Maria Vittoria} and Giovanni Fogliato and Giuseppe Querques and Francesco Bandello",
year = "2016",
month = "8",
day = "8",
doi = "10.1007/s00404-016-4170-2",
language = "English",
pages = "1--6",
journal = "Archives of Gynecology",
issn = "0170-9925",
publisher = "Springer Verlag",

}

TY - JOUR

T1 - Impact of combined hormonal contraceptives on vessels functionality

AU - Rabiolo, Alessandro

AU - Corvi, Federico

AU - Monteduro, Davide

AU - Benatti, Lucia

AU - Cicinelli, Maria Vittoria

AU - Fogliato, Giovanni

AU - Querques, Giuseppe

AU - Bandello, Francesco

PY - 2016/8/8

Y1 - 2016/8/8

N2 - Purpose: To evaluate the dynamic and static retinal vascular functionality in young females using combined hormonal contraceptive (CHC). Methods: Thirty-eight consecutive young female subjects were enrolled in this study between January 2015 and December 2015. Subjects were divided in two groups: CHC group, defined as CHC use for ≥6 months, and control group, defined as no current and prior CHC use. Participants underwent a dynamic and static retinal vessel analysis using the Dynamic Vessel Analyzer (DVA, Imedos, Jena, Germany). Results: Seventeen subjects continuously took CHC for 54.6 ± 29.3 months, while 21 subjects belonged to control group. No difference was found between the CHC and control groups for age (p = 0.1), smoking status (p = 0.6), and systolic (p = 0.3) and diastolic (p = 0.1) blood pressure. With regard to dynamic analysis, women taking CHC exhibited a marked significant vasoconstriction following flicker stimulation in comparison with control group (−2.43 ± 2.5 vs 0.63 ± 2.1, respectively; p = 0.0002). No significant difference was observed between groups for mean arterial (p = 0.2) and venous dilatations (p = 0.3), arteriovenous ratio (p = 0.09), central retinal artery equivalent (p = 0.4), and central retinal venous equivalent (p = 0.5). Conclusions: CHC may affect vessel reactivity to flicker light by increasing arteries constriction. This may reflect systemic changes in vascular functionality in subjects using CHC. Moreover, CHC should be considered as a confounding bias in studies involving DVA.

AB - Purpose: To evaluate the dynamic and static retinal vascular functionality in young females using combined hormonal contraceptive (CHC). Methods: Thirty-eight consecutive young female subjects were enrolled in this study between January 2015 and December 2015. Subjects were divided in two groups: CHC group, defined as CHC use for ≥6 months, and control group, defined as no current and prior CHC use. Participants underwent a dynamic and static retinal vessel analysis using the Dynamic Vessel Analyzer (DVA, Imedos, Jena, Germany). Results: Seventeen subjects continuously took CHC for 54.6 ± 29.3 months, while 21 subjects belonged to control group. No difference was found between the CHC and control groups for age (p = 0.1), smoking status (p = 0.6), and systolic (p = 0.3) and diastolic (p = 0.1) blood pressure. With regard to dynamic analysis, women taking CHC exhibited a marked significant vasoconstriction following flicker stimulation in comparison with control group (−2.43 ± 2.5 vs 0.63 ± 2.1, respectively; p = 0.0002). No significant difference was observed between groups for mean arterial (p = 0.2) and venous dilatations (p = 0.3), arteriovenous ratio (p = 0.09), central retinal artery equivalent (p = 0.4), and central retinal venous equivalent (p = 0.5). Conclusions: CHC may affect vessel reactivity to flicker light by increasing arteries constriction. This may reflect systemic changes in vascular functionality in subjects using CHC. Moreover, CHC should be considered as a confounding bias in studies involving DVA.

KW - Combined hormonal contraceptive

KW - Dynamic vessel analyzer

KW - Flicker light

KW - Oral contraceptive pill

KW - Retinal vessel analysis

KW - Static vessel analysis

UR - http://www.scopus.com/inward/record.url?scp=84981167254&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84981167254&partnerID=8YFLogxK

U2 - 10.1007/s00404-016-4170-2

DO - 10.1007/s00404-016-4170-2

M3 - Article

SP - 1

EP - 6

JO - Archives of Gynecology

JF - Archives of Gynecology

SN - 0170-9925

ER -